ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1566

Elevated IL-1 Expression Levels in Mesenchymal Stem Cells Derived from Spondyloarthitis Patients Might be Linked to Increased Osteoblast Mineralization

Gerlinde Layh-Schmitt1, Breanna Nguyen1, Emily Lazowick1, Stephen R. Brooks2 and Robert Colbert1, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2NIAMS/NIH, Biodata Mining & Discovery, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: axial spondyloarthritis, mesenchymal stem cells and osteoblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Axial spondyloarthritis (AxSpA) is an immune–mediated inflammatory disease involving the spine and sacroiliac joint. AxSpA is characterized by vertebral trabecular bone loss and progressive bone formation in the spine. To date, the root cause of osteoproliferation and aberrant bone formation is unknown. Therefore, we evaluated, (i) whether bone progenitor cells (mesenchymal cells (MSCs) and osteoblasts (OBs)) derived from AxSpA patients (P) exhibit differences in their capacity to form mineralizing osteoblasts in comparison to healthy controls (HC), and (ii) whether inflammatory cytokines alter osteoblastogenesis and gene expression patterns in MCSs.

Methods:  We used MSCs derived from induced pluripotent stem cells (iPSCs) generated from P and HC skin fibroblasts. MSCs from 3 HC and 5 P were differentiated into mineralizing osteoblasts. The influence of cytokines (combination of IFNγ/TNFα and IL-1β) and the IL-1 receptor anatgonist (IL-ra) on MSCs and osteoblastogenesis was examined. The degree of osteoblast calcification was measured by alizarin red stain. Cell numbers were determined by DAPI staining. Whole transcriptome expression profiles were established for MSCs with and without cytokine treatments by using RNA-seq and Nanostring. (3 HC and 4P). Standard approaches and statistical methods were used to analyze the data.

Results:  On average, OBs derived from P (n=5) exhibited a 1.4 fold higher mineralization capacity compared to OBs from HC (n=3) (p<0.05; Mann Whitney test). Interestingly, in all tested P IL-1α (n= 4) or IL-1β (n=3) mRNA levels were enriched compared to HC up to 5 fold (p<0.05). Stimulation with IFNγ & TNFα induced IL-1α and IL-1β up to 20-fold and COX2 up to 15-fold. Incubation of P and HC MSC lines with IL-1β for 24h induced IL-1β, IL-1α and COX2 expression 5,10-20, and 3-5 fold (p<0.05), respectively. Treatment of MSCs for 48h with IL-1β before differentiation, led to a 25% increase of OB numbers and the degree of mineralization was up 2.5 fold (p<0.05). This effect was prevented by IL-1ra, which inhibited base line mineralization by 15%.

Conclusion: The results suggest that, under certain conditions, IL-1 can enhance proliferation of bone progenitors and osteoblast mineralization by auto- or paracrine mechanisms. Interestingly, exogenous IL-1β induced IL-1α, IL1β, and COX2 in MSCs correlated with increased proliferation and mineralization of OB. Since COX2 is crucial for the synthesis of prostaglandin E2 (PGE2) which can mediate aberrant ossification through β-catenin stabilization, we will evaluate whether PGE2 and β-catenin are increased in patient cell lines in future studies.

 

 


Disclosure: G. Layh-Schmitt, None; B. Nguyen, None; E. Lazowick, None; S. R. Brooks, None; R. Colbert, None.

To cite this abstract in AMA style:

Layh-Schmitt G, Nguyen B, Lazowick E, Brooks SR, Colbert R. Elevated IL-1 Expression Levels in Mesenchymal Stem Cells Derived from Spondyloarthitis Patients Might be Linked to Increased Osteoblast Mineralization [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/elevated-il-1-expression-levels-in-mesenchymal-stem-cells-derived-from-spondyloarthitis-patients-might-be-linked-to-increased-osteoblast-mineralization/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-il-1-expression-levels-in-mesenchymal-stem-cells-derived-from-spondyloarthitis-patients-might-be-linked-to-increased-osteoblast-mineralization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology